Tu banner alternativo

YK-11

In today's article we are going to delve into the fascinating world of YK-11. From its origins to its impact today, we will explore all the relevant aspects that make YK-11 a topic of interest to both experts and those who are just beginning to delve into the subject. We will analyze the different approaches and opinions that exist around YK-11, as well as its influence on society, culture and the world in general. Get ready to immerse yourself in an informative and enriching journey that will lead you to discover a new perspective on YK-11.

Tu banner alternativo
YK-11
Clinical data
Other namesMyostine; YK-11; 17α-methyl-δ2-17β-hydroxyestra-4,9-dien-3-one
Identifiers
  • Methyl (2E)-2-phenanthrene-17,5'-1,3-dioxolane]-4'-ylidene]acetate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC25H34O6
Molar mass430.541 g·mol−1
3D model (JSmol)
  • C12CC3(1CC24/C(=C\C(=O)OC)/OC(O4)(C)OC)CCC5=CC(=O)CC35
  • InChI=1S/C25H34O6/c1-23-11-9-18-17-8-6-16(26)13-15(17)5-7-19(18)20(23)10-12-25(23)21(14-22(27)28-3)30-24(2,29-4)31-25/h13-14,17-20H,5-12H2,1-4H3/b21-14+/t17-,18+,19+,20-,23-,24?,25+/m0/s1
  • Key:KCQHQCDHFVGNMK-PQUNLUOYSA-N

YK-11 is a synthetic, steroidal selective androgen receptor modulator (SARM) structurally derived from dihydrotestosterone (DHT). It is currently classified as an experimental compound and has not been approved for medical use in humans. Despite this, it has been widely researched in preclinical settings for its potent anabolic effects on muscle cells.

Overview

YK-11 is distinct among SARMs due to its steroidal structure, setting it apart from most non-steroidal SARMs like Ostarine or LGD-4033. It binds to the androgen receptor (AR), similar to anabolic steroids, but its downstream activity differs significantly.

Mechanism of action

YK-11 functions as a partial agonist of the androgen receptor. It activates the receptor but not to the full extent like natural androgens such as testosterone or DHT. It does not promote the typical N/C-terminal interaction within the AR, which is required for full transcriptional activation.[1]

Instead, YK-11 induces muscle growth through a secondary mechanism: it significantly increases the expression of follistatin, a potent inhibitor of myostatin—a protein that suppresses muscle growth.[2]

In vitro and animal studies

Laboratory studies on mouse and human myoblasts (muscle precursor cells) have shown that:

  • YK-11 increases muscle cell differentiation and growth more potently than DHT.[2]
  • It exhibits strong anabolic activity without stimulating androgenic effects on non-muscle tissue (though this has only been evaluated in vitro so far).
  • In animal models, it has demonstrated protective effects against muscle wasting due to sepsis, suggesting potential therapeutic uses.[3]


See also

References

  1. ^ Kanno Y, Hikosaka R, Zhang SY, Inoue Y, Nakahama T, Kato K, et al. (2011). "(17α,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester (YK11) is a partial agonist of the androgen receptor". Biological & Pharmaceutical Bulletin. 34 (3): 318–323. doi:10.1248/bpb.34.318. PMID 21372378.
  2. ^ a b Kanno Y, Ota R, Someya K, Kusakabe T, Kato K, Inouye Y (2013). "Selective androgen receptor modulator, YK11, regulates myogenic differentiation of C2C12 myoblasts by follistatin expression". Biological & Pharmaceutical Bulletin. 36 (9): 1460–1465. doi:10.1248/bpb.b13-00231. PMID 23995658.
  3. ^ Lee SJ, Gharbi A, Shin JE, Jung ID, Park YM (March 2021). "Myostatin inhibitor YK11 as a preventative health supplement for bacterial sepsis". Biochemical and Biophysical Research Communications. 543: 1–7. doi:10.1016/j.bbrc.2021.01.030. PMID 33588136.

This article about an estrane is a stub. You can help Wikipedia by expanding it.

Stub icon

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

Wikious
Boobota
Sagapedia